Management of low cardiac output syndrome after cardiac surgery using enoximone
- 1 May 1990
- journal article
- case report
- Published by Wiley in Anaesthesia
- Vol. 45 (5) , 386-389
- https://doi.org/10.1111/j.1365-2044.1990.tb14783.x
Abstract
This case report describes the use of enoximone, a potent phosphodiesterase F-IV inhibitor with inotropic and vasodilator actions, to treat low output syndrome after cardiac surgery. The reduced cardiac output was unresponsive to a combination of inotropic drugs and intra-aortic balloon counterpulsation was contraindicated. Cardiac output was increased dramatically by enoximone, but systemic vascular resistance and perfusion pressure remained low until the addition of metaraminol.Keywords
This publication has 11 references indexed in Scilit:
- The inotropic effect of enoximone and its potentiation of adrenoreceptor agonistsJournal of Cardiothoracic Anesthesia, 1989
- Administration of enoximone in cardiogenic shockThe American Journal of Cardiology, 1988
- Efficacy of enoximone in the management of refractory low-output states following cardiac surgeryJournal of Cardiothoracic Anesthesia, 1988
- Pharmacology of enoximoneThe American Journal of Cardiology, 1987
- IntroductionThe American Journal of Cardiology, 1987
- Physiologic response to the inotropic and vasodilator properties of enoximoneThe American Journal of Cardiology, 1987
- Reduction in Pulmonary Hypertension and in Airway Resistances by Enoximone (MDL 17,043) in Decompensated COPDChest, 1987
- Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failureAmerican Heart Journal, 1984
- Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failureJournal of the American College of Cardiology, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982